HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pete Kaiser Selected Research

Malaria

2/2005Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pete Kaiser Research Topics

Disease

35Infections
02/2022 - 01/2003
4Inflammation (Inflammations)
11/2018 - 12/2003
4Salmonella Infections (Salmonellosis)
02/2006 - 11/2003
3Disease Resistance
01/2013 - 10/2010
2Weight Gain
11/2018 - 02/2008
2Marek Disease (Marek's Disease)
01/2017 - 01/2003
2Virus Diseases (Viral Diseases)
01/2015 - 01/2003
2Meckel Diverticulum
01/2013 - 02/2010
2Necrosis
12/2012 - 06/2008
1Acute-Phase Reaction
01/2019
1Coccidiosis
11/2018
1Respiratory Tract Diseases (Respiratory Tract Disease)
10/2018
1Wounds and Injuries (Trauma)
08/2014
1Human Influenza (Influenza)
07/2013
1Bird Diseases (Disease, Avian)
10/2010
1Superinfection
08/2010
1Fetal Death
06/2008
1Hypertriglyceridemia
02/2008
1Hypercholesterolemia
02/2008
1Coinfection
08/2005
1Granuloma
08/2005
1Campylobacter Infections (Campylobacter Infection)
04/2005
1Acquired Immunodeficiency Syndrome (AIDS)
02/2005
1Malaria
02/2005
1Neoplasms (Cancer)
02/2005
1Tuberculosis (Tuberculoses)
02/2005
1Bacterial Infections (Bacterial Infection)
12/2003
1Porcine Reproductive and Respiratory Syndrome (PRRS)
06/2003
1Lymphoma (Lymphomas)
01/2003
1Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
04/2002

Drug/Important Bio-Agent (IBA)

21CytokinesIBA
02/2022 - 01/2003
11Messenger RNA (mRNA)IBA
02/2010 - 06/2003
8ChemokinesIBA
03/2015 - 04/2004
5Interleukin-10 (Interleukin 10)IBA
11/2018 - 06/2008
5VaccinesIBA
10/2018 - 02/2005
4Interleukin-18 (Interleukin 18)IBA
08/2010 - 01/2003
3Biological ProductsIBA
01/2019 - 01/2013
3AntigensIBA
08/2014 - 02/2005
3Interleukin-6 (Interleukin 6)IBA
08/2010 - 01/2003
2Proteins (Proteins, Gene)FDA Link
01/2015 - 06/2008
2Immunoglobulin A (IgA)IBA
02/2014 - 08/2005
2transforming growth factor beta4IBA
08/2010 - 08/2005
2Interferon-gamma (Interferon, gamma)IBA
06/2008 - 08/2005
2Immunoglobulin G (IgG)IBA
08/2005 - 06/2003
1RNA (Ribonucleic Acid)IBA
01/2021
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2019
1Biomarkers (Surrogate Marker)IBA
11/2018
1Dust (House Dust)FDA Link
05/2017
1CXC ChemokinesIBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
10/2015
1Antiviral Agents (Antivirals)IBA
03/2015
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2015
1Transcription Factors (Transcription Factor)IBA
01/2015
1Carrier Proteins (Binding Protein)IBA
01/2015
1Interleukin-13IBA
12/2014
1IgYIBA
02/2014
1DefensinsIBA
07/2013
1ButyrophilinsIBA
07/2013
1Genetic Markers (Genetic Marker)IBA
01/2013
1Interleukin-1 (Interleukin 1)IBA
12/2012
1Synthetic Vaccines (Recombinant Vaccines)IBA
11/2012
1Oxygen (Dioxygen)IBA
05/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2012
1Vaccine AdjuvantsIBA
10/2010
1Interleukin-12 Subunit p40IBA
06/2008
1Single-Stranded DNA (DNA, Single Stranded)IBA
06/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2008
1Interleukin-4 (Interleukin 4)IBA
06/2008
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2008
1Interleukin-2 (IL2)IBA
06/2008
1CorticosteroneIBA
02/2008
1Cyclin D1IBA
04/2007
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2006
1Interleukin-12 (IL 12)IBA
01/2006
1Dihydrotachysterol (AT 10)IBA
11/2005
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
08/2005
1Immunoglobulin M (IgM)IBA
08/2005
1Toll-Like Receptor 1IBA
03/2005
1Immunologic Factors (Immunomodulators)IBA
02/2005
1Toll-Like Receptor 2IBA
11/2003
1Toll-Like Receptors (Toll-Like Receptor)IBA
11/2003
1Viral DNAIBA
01/2003
1Interleukin-15 (Interleukin 15)IBA
04/2002